Norges Bank Makes New $29.03 Million Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Norges Bank bought a new position in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 3,082,036 shares of the biopharmaceutical company’s stock, valued at approximately $29,033,000. A number of other hedge funds and other institutional investors have also made […]